Research direction and topic options
1, immune checkpoint related bisspecific antibody construction and tumor immunotherapy mechanism research;
2. Research on the mechanism of immune cell recruitment of bisecific antibodies for tumor therapy and development of candidate drugs;
3. Drug development and preclinical research of tumor vaccines;
4. Study on the clinical safety, effectiveness and mechanism of action of EpCAM/CD3 bispecial antibody in patients with malignant pleural effusion;
5. Research on large-scale production process of bisspecific antibodies and establishment of international quality standards;
6, nano antibody technology and nano drug delivery technology development and corresponding clinical transformation research;
7. Study on the structure, biological activity and function of double-characteristic antibody。

1, domestic and foreign doctoral graduates, the age of less than 35 years old;

2, immunology, tumor biology, biopharmaceutical, medical and other related professional research experience is preferred;

3. Excellent English reading and writing ability, international vision and team spirit, willing to engage in innovative research work and achieve excellent results;

4, with good academic ethics and rigorous scientific attitude, good health, can meet the job requirements。